Arteriovenous fistula patency associated with angiotensin-converting enzyme I/D polymorphism and ACE inhibition or AT1 receptor blockade

Nephron - Clinical Practice

Volumn 111, Issue 2, 2009, Pages

  Moon, Ju Young ^a   Jeong, Kyung Hwan ^b   Paik, Seung Sook ^b   Han, Jae Joon ^b   Lee, Sang Ho ^a   Lee, Tae Won ^b   Ihm, Chun Gyoo ^b   Kim, Myung Jae ^a   Chung, Joo Ho ^b  

^a Kyung Hee University College of Medicine   (South Korea)

^b Kyung Hee University   (South Korea)

Author keywords

Angiotensin converting enzyme; Arteriovenous fistula; Hemodialysis; Polymorphism

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PHOSPHORUS;

ADULT; ARTERIOVENOUS FISTULA; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETIC NEPHROPATHY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HEMODIALYSIS PATIENT; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; VASCULAR PATENCY;

ADULT; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ARTERIOVENOUS SHUNT, SURGICAL; FEMALE; FOLLOW-UP STUDIES; GENE DELETION; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MUTAGENESIS, INSERTIONAL; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; RECEPTOR, ANGIOTENSIN, TYPE 1; VASCULAR PATENCY;

EID: 58149360942     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000191201     Document Type: Article

References (26)

1. Windus DW: Permanent vascular access: a nephrologist's view. Am J Kidney Dis 1993;21:457-471.
2. Weiss MF, Scivittaro V, Anderson JM: Oxidative stress and increased expression of growth factors in lesions of failed hemodialysis access. Am J Kidney Dis 2001;37:970-980.
3. Daemen MJ, Lombardi DM, Bosman FT, Schwartz SM: Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ Res 1991;68:450-456.
4. Liu SQ: Focal expression of angiotensin II type 1 receptor and smooth muscle cell proliferation in the neointima of experimental vein grafts: relation to eddy blood flow. Arterioscler Thromb Vasc Biol 1999;19:2630-2639.
5. Tiret L, Rigat B, Visvikis S, Breda C, Corvol P, Cambien F, Soubrier F: Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 1992;51:197-205.
6. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003;42:S1-S201.
7. van der Sman-de Beer F, Verhagen C, Rombach SM, Boorsma P, van Manen JG, Korevaar JC, van den Bogaard R, Boeschoten EW, Krediet RT, Navis GJ, Vandenbroucke JP, Dekker FW: ACE I/D polymorphism is associated with mortality in a cohort study of patients starting with dialysis. Kidney Int 2005;68:2237-2243.
8. So WY, Ma RC, Ozaki R, Tong PC, Ng MC, Ho CS, Lam CW, Chow CC, Chan WB, Kong AP, Chan JC: Angiotensin-converting enzyme (ACE) inhibition in type 2, diabetic patients: interaction with ACE insertion/deletion polymorphism. Kidney Int 2006;69:1438-1443.
9. Ishimitsu T, Hosoya K, Matsuoka H: The deletion allele of angiotensin-converting enzyme gene polymorphism as a cardiovascular risk factor in patients undergoing long-term hemodialysis. Ann Intern Med 2000;133:924.
10. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F: An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990;86:1343-1346.
11. Dayi SU, Tartan Z, Terzi S, Kasikcioglu H, Uyarel H, Orhan G, Alper AT, Ciloglu F, Cam N: Influence of angiotensin converting enzyme insertion/deletion polymorphism on long-term total graft occlusion after coronary artery bypass surgery. Heart Surg Forum 2005;8:E373-E377.
12. Heine GH, Ulrich C, Sester U, Sester M, Kohler H, Girndt M: Transforming growth factor beta1 genotype polymorphisms determine AV fistula patency in hemodialysis patients. Kidney Int 2003;64:1101-1107.
13. Fukasawa M, Matsushita K, Kamiyama M, Mikami Y, Araki I, Yamagata Z, Takeda M: The methylentetrahydrofolate reductase C677T point mutation is a risk factor for vascular access thrombosis in hemodialysis patients. Am J Kidney Dis 2003;41:637-642.
14. Heine GH, Ulrich C, Kohler H, Girndt M: Is AV fistula patency associated with angiotensin-converting enzyme (ACE) polymorphism and ACE inhibitor intake? Am J Nephrol 2004;24:461-468.
15. Lin CC, Yang WC, Lin SJ, Chen TW, Lee WS, Chang CF, Lee PC, Lee SD, Su TS, Fann CS, Chung MY: Length polymorphism in heme oxygenase-1 is associated with arteriovenous fistula patency in hemodialysis patients. Kidney Int 2006;69:165-172.
16. Rodriguez JA, Armadans L, Ferrer E, Olmos A, Codina S, Bartolome J, Borrellas J, Piera L: The function of permanent vascular access. Nephrol Dial Transplant 2000;15:402-408.
17. Shrestha PC, Asher J, Shrestha SM, Jenner S, Wilson C, Taylor C, Rewcastle T, Handerson D, Wilson M, Rix D, Talbot D: Survival of arteriovenous fistula for dialysis at different centers in the north of england. J Vasc Access 2007;8:231-234.
18. Wang AY, Chan JC, Wang M, Poon E, Lui SF, Li PK, Sanderson J: Cardiac hypertrophy and remodeling in relation to ace and angiotensinogen genes genotypes in Chinese dialysis patients. Kidney Int 2003;63:1899-1907.
19. Higashiuesato Y, Tana T, Tozawa M, Iseki C, Iseki K, Fukiyama K, Takishita S: Angiotensin-converting enzyme (ACE) insertion/deletion polymorphism and survival in a cohort of chronic hemodialysis patients. Clin Nephrol 2002;58:370-375.
20. Aucella F, Margaglione M, Vigilante M, Gatta G, Grandone E, Forcella M, Ktena M, De Min A, Salatino G, Procaccini DA, Stallone C: PAI-1 4G/5G and ACE I/D gene polymorphisms and the occurrence of myocardial infarction in patients on intermittent dialysis. Nephrol Dial Transplant 2003;18:1142-1146.
21. Jin D, Ueda H, Takai S, Okamoto Y, Muramatsu M, Sakaguchi M, Shibahara N, Katsuoka Y, Miyazaki M: Effect of chymase inhibition on the arteriovenous fistula stenosis in dogs. J Am Soc Nephrol 2005;16:1024-1034.
22. Saran R, Dykstra DM, Wolfe RA, Gillespie B, Held PJ, Young EW: Association between vascular access failure and the use of specific drugs: The dialysis outcomes and practice patterns study (DOPPS). Am J Kidney Dis 2002;40:1255-1263.
23. Erkut B, Unlu Y, Ceviz M, Becit N, Ates A, Colak A, Kocak H: Primary arteriovenous fistulas in the forearm for hemodialysis: effect of miscellaneous factors in fistula patency. Renal Fail 2006;28:275-281.
24. Woods JD, Turenne MN, Strawderman RL, Young EW, Hirth RA, Port FK, Held PJ: Vascular access survival among incident hemodialysis patients in the United States. Am J Kidney Dis 1997;30:50-57.
25. Block GA, Hulbert-Shearon TE, Levin NW, Port FK: Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 1998;31:607-617.
26. Block GA: Prevalence and clinical consequences of elevated Ca x P product in hemodialysis patients. Clin Nephrol 2000;54:318-324.